PATIENTS' PERSPECTIVES ON ORAL DECITABINE AND CEDAZURIDINE FOR THE TREATMENT OF MYELODYSPLASTIC SYNDROMES

被引：1
|
作者：
Zeidan, A. [1 ]
Perepezko, K. [2 ]
Salimi, T. [3 ]
Washington, T. [3 ]
Epstein, R. [4 ]
机构：
[1] Yale Canc Ctr, Hematol, New Haven, CT USA
[2] CorEvitas Llc, Waltham, MA USA
[3] Taiho Oncol Inc, Princeton, NJ USA
[4] Epstein Hlth Llc, Woodcliff Lake, NJ USA
来源：
LEUKEMIA RESEARCH | 2023年 / 128卷
关键词：
D O I：
10.1016/j.leukres.2023.107127
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O14
引用
收藏
页数：2
相关论文
共 50 条
  • [31] PROLONGED SURVIVAL OBSERVED IN 133 MDS PATIENTS TREATED WITH ORAL DECITABINE/CEDAZURIDINE
    Savona, M.
    Mccloskey, J.
    Griffiths, E.
    Yee, K.
    Al-Kali, A.
    Zeidan, A. M.
    Deeg, H. J.
    Patel, P.
    Sabloff, M.
    Keating, M. -M.
    Dao, K. -H.
    Zhu, N.
    Gabrail, N.
    Fazal, S.
    Maly, J.
    Odenike, O.
    Kantarjian, H.
    Dezern, A.
    O'Connell, C.
    Roboz, G.
    Busque, L.
    Wells, R.
    Amin, H.
    Randhawa, J.
    Leber, B.
    Hao, Y.
    Keer, H.
    Azab, M.
    Manero, G. Garcia
    LEUKEMIA RESEARCH, 2021, 108 : S45 - S45
  • [32] Cytogenetic response features in the patients with myelodysplastic syndromes following lower dosage of decitabine treatment
    Li, X.
    Chang, C. K.
    Qi, H.
    Xu, F.
    Wu, L. Y.
    Su, J. Y.
    Zhang, X.
    Zhou, L. Y.
    Wu, D.
    Song, L. X.
    Zhang, Z.
    LEUKEMIA RESEARCH, 2013, 37 : S148 - S148
  • [33] Oral Decitabine/Cedazuridine in Patients with Lower Risk Myelodysplastic Syndrome: A Longer-Term Follow-up of from the Ascertain Study
    Garcia-Manero, Guillermo
    McCloskey, James K.
    Griffiths, Elizabeth A.
    Yee, Karen
    Gabrail, Amer Y.
    Fazal, Salman
    Maly, Joseph
    Odenike, Olatoyosi
    Kantarjian, Hagop
    De Zern, Amy E.
    O'Connell, Casey L.
    Roboz, Gail J.
    Busque, Lambert
    Wells, Richard A.
    Amin, Harshad
    Randhawa, Jasleen K.
    Leber, Brian
    Hao, Yong
    Keer, Harold N.
    Azab, Mohammad
    Savona, Michael R.
    BLOOD, 2021, 138
  • [34] Comparative analysis between azacitidine and decitabine for the treatment of myelodysplastic syndromes
    Lee, Yun-Gyoo
    Kim, Inho
    Yoon, Sung-Soo
    Park, Seonyang
    Cheong, June Won
    Min, Yoo Hong
    Lee, Jeong-Ok
    Bang, Soo-Mee
    Yi, Hyeon Gyu
    Kim, Chul Soo
    Park, Yong
    Kim, Byung-Soo
    Mun, Yeung-Chul
    Seong, Chu-Myoung
    Park, Jinny
    Lee, Jae Hoon
    Kim, Sung-Yong
    Lee, Hong Ghi
    Kim, Yeo-Kyeoung
    Kim, Hyeoung-Joon
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 161 (03) : 339 - 347
  • [35] Clinical Experience of Decitabine in Elderly Patients with Myelodysplastic Syndromes (MDS)
    Geils, George F., Jr.
    BLOOD, 2009, 114 (22) : 1092 - 1092
  • [36] Decitabine in myelodysplastic syndromes: profile report
    Drugs & Therapy Perspectives, 2006, 22 (11) : 6 - 7
  • [37] PHASE 1 STUDY EVALUATING LOW-DOSE (LD) ORAL DECITABINE/CEDAZURIDINE (ASTX727) IN LOWER-RISK MYELODYSPLASTIC SYNDROMES (LR-MDS) PATIENTS
    Garcia-Manero, G.
    Bachiashvili, K.
    Amin, H.
    Traer, E.
    Pollyea, D.
    Sallman, D.
    Al-Kali, A.
    Cripe, L.
    Berdeja, J.
    Griffiths, E.
    Mohan, S.
    Vachhani, P.
    Sano, Y.
    Oganesian, A.
    Keer, H.
    Yacoub, A.
    LEUKEMIA RESEARCH, 2023, 128
  • [38] Oral Decitabine/Cedazuridine Is a Tolerable and Effective Ambulatory Regimen for Patients with Advanced Myeloproliferative Neoplasms
    Sivakumar, Ganesh
    Handa, Shivani
    Srisuwananukorn, Andrew
    Tremblay, Douglas
    Mascarenhas, John
    Kremyanskaya, Marina
    Ginzburg, Yelena
    Wang, Xiaoli
    Hoffman, Ronald
    BLOOD, 2023, 142
  • [39] New landscapes in the management of myelodysplastic syndromes and chronic myelomonocytic leukemia: oral decitabine
    Niscola, Pasquale
    Mazzone, Carla
    Molica, Matteo
    Fabritiis, Paolo de
    FUTURE ONCOLOGY, 2021, 17 (16) : 1973 - 1975
  • [40] Comparative Effectiveness of Azacitidine Versus Decitabine for the Treatment of Myelodysplastic Syndromes.
    Reljic, Tea
    Bhansali, Neera
    Komrokji, Rami S.
    Lin, Karen
    List, Alan F.
    Djulbegovic, Benjamin
    Fenstermacher, David A.
    Lancet, Jeffrey E.
    Miladinovic, Branko
    Kumar, Ambuj
    BLOOD, 2010, 116 (21) : 1628 - 1628
12345